News & Events
A New Discovery
August 1st, 2023
NuChem is delighted to announce its acquisition by leading integrated drug discovery provider, Sygnature Discovery.
This acquisition cements Sygnature as
2nd NuChem Symposium 2023
September 22, 2023
We are thrilled to announce the upcoming NuChem Sciences Symposium, a unique event designed to foster collaboration and bridge the gap between academia and industry in the field of biology and medicinal chemistry for drug discovery.
NuChem ranks 44th of the top 300 most important small and medium enterprises in Quebec
October 26, 2022
On the annual top 300 list produced by Les Affaires NuChem ranked in the top 50, and is the only Contract Research Organization (CRO) on the list, which is considered a benchmark for the entrepreneurial community.
NuChem awards for the 2nd time its industrial scholarship to two promising students
October 4, 2022
One year ago, the first industrial scholarship was awarded to three students in their final year of doctoral studies. NuChem Sciences has reiterated its commitment to the training of future scientific researchers in university by awarding this scholarship for the second time.
September 16: OmegaChem to host its first Omega Symposium
August 9, 2022
As a major employer of world-class scientific talent in the Quebec City area, OmegaChem is proud to host the first-ever Omega Symposium!
NuChem Sciences inaugurates its new laboratories and receives the Medal of the National Assembly of Quebec
July 14, 2022
NuChem’s leaders, scientists and support staff joined some 60 guests to inaugurate the world-class laboratories in Dobrin Street, Montreal.
NuChem Sciences: 10 years of accelerating drug discovery. Together.
June 20, 2022
As we celebrate the 10th anniversary of NuChem Sciences, here are the highlights of our company’s past achievements and its vision for an even brighter future.
NuChem Sciences awards scholarships to three promising students in Canadian universities
September 23, 2021
NuChem Sciences is pleased to announce a new fellowship to support and mentor three outstanding doctoral graduate students in the fields of organic synthesis or medicinal chemistry.
NuChem Sciences joins forces with OmegaChem to become Canada’s CRO focused on chemistry
September 3, 2021
We are pleased to announce that NuChem Sciences is joining forces with OmegaChem to become Canada’s CRO focused on chemistry.
Minister of labour J. Boulet visits Nuchem Sciences
August 8, 2021
We had the pleasure of hosting a visit of Mr. Jean Boulet, the Minister of Labour, Employment and Social Solidarity and Minister responsible for the Mauricie region, in our state-of-the-art laboratories to discuss with members of our teams.
NuChem Sciences announces new Discovery Partner Program™
April 15, 2021
This new service offers our team’s superior talent and our cutting-edge scientific technology, paired with responsive communication, efficiency and clarity along the drug discovery journey.
NuChem Sciences launches new brand and announces new name
April 15, 2021
After experiencing exponential growth in recent years, NuChem Therapeutics is proud to launch its new brand identity. As part of this exciting step forward, we will adopt a new corporate name: NuChem Sciences.
Universite de Montreal Journee Carriere
January 15, 2020
Our team was happy to meet and greet students at the Universite de Montreal MIL Campus as part of the Journee Carriere event.
NuChem Therapeutics Completed the Acquisition of Amplia Pharmatek
October 19, 2019
Amplia Pharmatek is an innovative service provider who specializes in Discovery Biology, in vivo Pharmacology, Pharmacokinetics and Toxicology.
Completion of a Successful Management Buyout Transaction At NuChem Therapeutics
February 22, 2019
On December 13th 2018, senior management of the company, comprised of Marc LeBel, Daniel Guay, Marc Janes and John Mancuso, acquired 95% of the voting shares from Amorchem LP, the venture capital fund which founded NuChem in 2011.